Biologica provides supplements designed to support women through the reproductive years, perimenopause, and post menopause stages.
Biologica has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Biologica's investors include Greycroft, True Beauty Ventures, Hawktail Management, Good Friends, Addition Capital.
Biologica is headquartered in San Francisco, United States.
Biologica provides supplements designed to support women through the reproductive years, perimenopause, and post menopause stages.
Biologica is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biologica — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/biologica. Accessed July 19, 2026.
VCBacked. (2025). Biologica — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/biologica
{{cite web |title=Biologica — Funding & Investors |url=https://www.vcbacked.co/company/biologica |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated